Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan.
Department of Psychiatry, University of Michigan, Ann Arbor, Michigan.
Depress Anxiety. 2020 Oct;37(10):1037-1046. doi: 10.1002/da.23075. Epub 2020 Jul 15.
Alterations in resting-state functional connectivity (rsFC) have been reported in posttraumatic stress disorder (PTSD). Here, we examined pre- and post-treatment rsFC during a randomized clinical trial to characterize alterations and examine predictors of treatment response.
Sixty-four combat veterans with PTSD were randomly assigned to prolonged exposure (PE) plus placebo, sertraline plus enhanced medication management, or PE plus sertraline. Symptom assessment and resting-state functional magnetic resonance imaging (fMRI) scans occurred before and after treatment. Twenty-nine trauma-exposed combat veterans without PTSD served as a control group at intake. Seed-based and region of interest (ROI)-to-ROI connectivities, as well as an exploratory connectome-based approach were used to analyze rsFC patterns. Based on previously reported findings, analyses focused on Salience Network (SN) and Default-Mode Network (DMN).
At intake, patients with PTSD showed greater DMN-dorsal attention network (DAN) connectivity (between ventromedial prefrontal cortex and superior parietal lobule; family-wise error corrected p = .011), greater SN-DAN connectivity (between insula and middle frontal gyrus; corrected p = .003), and a negative correlation between re-experiencing symptoms and within-DMN connectivity (between posterior cingulate cortex (PCC) and middle temporal gyrus; corrected p < .001). We also found preliminary evidence for associations between rsFC and treatment response. Specifically, high responders (≥50% PTSD symptom improvement), compared with low responders, had greater SN-DMN segregation (i.e., less pre-treatment amygdala-PCC connectivity; p = .011) and lower pre-treatment global centrality (p = .042).
Our findings suggest neural abnormalities in PTSD and may inform future research examining neural biomarkers of PTSD treatment response.
创伤后应激障碍(PTSD)患者的静息态功能连接(rsFC)发生了改变。在此,我们在一项随机临床试验中检查了治疗前后的 rsFC,以描述改变并检查治疗反应的预测因子。
64 名患有 PTSD 的退伍军人被随机分配到延长暴露(PE)加安慰剂、舍曲林加增强药物管理或 PE 加舍曲林组。在治疗前后进行症状评估和静息态功能磁共振成像(fMRI)扫描。29 名无 PTSD 的创伤暴露的退伍军人作为对照组在摄入时进行评估。基于先前的报告结果,分析侧重于显着性网络(SN)和默认模式网络(DMN)。
在摄入时,PTSD 患者的 DMN-背侧注意网络(DAN)连接性(腹内侧前额叶皮质和顶叶上回之间;校正后的全脑错误率 p=0.011)、SN-DAN 连接性(岛叶和额中回之间;校正后的 p=0.003)较高,并且重新体验症状与 DMN 内连接性之间存在负相关(后扣带回皮层(PCC)和颞中回之间;校正后的 p<0.001)。我们还发现了 rsFC 与治疗反应之间关联的初步证据。具体来说,与低反应者(≥50% PTSD 症状改善)相比,高反应者(≥50% PTSD 症状改善)具有更大的 SN-DMN 分离(即,治疗前杏仁核-PCC 连接性较低;p=0.011)和较低的治疗前全局中心性(p=0.042)。
我们的研究结果表明 PTSD 存在神经异常,可能为未来研究 PTSD 治疗反应的神经生物标志物提供信息。